STUDY OBJECTIVE: Human papillomavirus (HPV) vaccines will soon be available for
clinical use, and the effectiveness of vaccine delivery programs will depend largely upon …

Routine vaccination with three doses of human papillomavirus (HPV) vaccine is
recommended for adolescent girls and boys at 11 or 12 years of age; however, vaccine …

Background: Improving the quality of physicians' recommendations for human
papillomavirus (HPV) vaccination is critical to addressing low coverage. Thus, we sought to …

WHY WAS HUMAN papillomavirus (HPV) vaccine different from all other vaccines? For
other routine vaccines included in the child and adolescent immunization schedules …

Human papillomavirus (HPV) can infect the tonsillar tissues of the oropharynx and is
associated with oropharyngeal squamous cell carcinoma. This article provides an overview …

OBJECTIVE: The goal was to describe factors associated with human papillomavirus (HPV)
vaccination series initiation (≥ 1 dose) and completion (≥ 3 doses) and parents' intent to …

Objectives With rates of the human papillomavirus (HPV) vaccination remaining low and
rates of oropharyngeal cancer rising, engaging new partners to promote vaccination is …

As detailed in this online CME activity (http://cmeaccess. com/cme/JAH_HPV_program/index
. asp? link_id= 2), human papillomavirus (HPV) infection is the cause of cervical cancer and …

The recent literature on adolescent knowledge about HPV and attitudes about HPV vaccines
supports the importance of designing developmentally appropriate educational materials for …

PURPOSE: To define factors that providers perceive as affecting their administration of
human papillomavirus (HPV) vaccination in their clinical practices. METHODS: We …